AKP-001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAKP-001
Drug Alias NameAKP-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 γ mitogen-activated protein kinase inhibitors
TargetsP38 γ mitogen-activated protein kinase
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAska Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAska Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A